Clinical Case Reports (Apr 2020)

Serum free light chains and multiple myeloma: Is it time to extend their application?

  • Uros Markovic,
  • Valerio Leotta,
  • Daniele Tibullo,
  • Rachele Giubbolini,
  • Alessandra Romano,
  • Vittorio Del Fabro,
  • Nunziatina Laura Parrinello,
  • Maria Teresa Cannizzaro,
  • Francesco Di Raimondo,
  • Concetta Conticello

DOI
https://doi.org/10.1002/ccr3.2636
Journal volume & issue
Vol. 8, no. 4
pp. 617 – 624

Abstract

Read online

Abstract In nonsecretory, oligo‐secretory, and light chain multiple myeloma patients, serial sFLC evaluation could precede biochemical and clinical disease progression, even in extramedullary relapse, thus initiating early treatment with novel anti‐MM agents.

Keywords